Some progress in the pipeline reported at ICAAC.
Gaylord
G
G
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D019380:Anti-HIV Agents